학술논문
Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults.
Document Type
Article
Author
Source
Human Vaccines & Immunotherapeutics; 2023, Vol. 19 Issue 2, p1-12, 12p
Subject
Language
ISSN
21645515